Dendritic cells (DCs) are composed of multiple subsets that play a dual role in inducing immunity and tolerance. However, it is unclear how CD205
conventional dendritic cells impacts the regulation of T-cell immunity and homeostasis in vivo
Edited by Ruslan Medzhitov, Yale University School of Medicine, New Haven, CT, and approved June 8, 2012 (received for review February 6, 2012) Dendritic cells (DCs) are composed of multiple subsets that play a dual role in inducing immunity and tolerance. However, it is unclear how CD205
+ conventional DCs (cDCs) control immune responses in vivo. Here we generated knock-in mice with the selective conditional ablation of CD205 + cDCs. CD205 + cDCs contributed to antigenspecific priming of CD4 + T cells under steady-state conditions, whereas they were dispensable for antigen-specific CD4 + T-cell responses under inflammatory conditions. In contrast, CD205 + cDCs were required for antigen-specific priming of CD8 + T cells to generate cytotoxic T lymphocytes (CTLs) mediated through crosspresentation. Although CD205
+ cDCs were involved in the thymic generation of CD4 + regulatory T cells (Tregs), they maintained the homeostasis of CD4 + Tregs and CD4 + effector T cells in peripheral and mucosal tissues. On the other hand, CD205
+ cDCs were involved in the inflammation triggered by Toll-like receptor ligand as well as bacterial and viral infections. Upon microbial infections, CD205 + cDCs contributed to the cross-priming of CD8 + T cells for generating antimicrobial CTLs to efficiently eliminate pathogens, whereas they suppressed antimicrobial CD4 + T-cell responses. Thus, these findings reveal a critical role for CD205
+ cDCs in the regulation of T-cell immunity and homeostasis in vivo.
knock-in mouse | innate immunity | adaptive immunity D endritic cells (DCs) are essential antigen-presenting cells (APCs) that consist of heterogeneous subsets, mainly classified as conventional DCs (cDCs) and plasmacytoid DCs (pDCs) (1) . DCs serve as sentinels, recognizing the presence of invading pathogens or virus-infected cells through various patternrecognition receptors, including Toll-like receptors (TLRs) (1) . DCs process such exogenous antigens intracellularly and present them to CD4 + T cells via MHC class II (MHC II) for induction of CD4 + effector T (Teff) cells (1) (2) (3) . DCs also show an unusual specialization in their MHC class I (MHC I) presentation pathway to prime CD8 + T cells. Although most cells use MHC I molecules to present peptides derived from endogenously synthesized proteins, DCs have the capacity to deliver exogenous antigens to the MHC I pathway, a phenomenon known as cross-presentation, that underlies the generation of cytotoxic T lymphocyte (CTL) immunity (1) (2) (3) . DCs thereby play a critical role in the link between innate and adaptive immunity. Conversely, DCs are also crucial for the induction of immunological tolerance under steady-state conditions, and the mechanisms involved include recessive tolerance mediated by deletion and anergy, and dominant tolerance by maintaining the homeostasis of self-reactive CD4
+

Foxp3
+ naturally occurring regulatory T cells (nTregs) and de novo generation of antigen-specific CD4
+
Foxp3
+ inducible Tregs (iTregs) (4-7). Mouse cDCs in lymphoid organs are comprised of two major subsets, classified as CD8α + cDCs and CD8α − cDCs. CD8α + cDCs mainly reside in the T-cell zone, and CD8α − cDCs reside in the red pulp and marginal zone (2, 8) . Series of in vitro and ex vivo studies reported that CD8α
+ cDCs compared with CD8α
− cDCs strongly generate T-helper cell type 1 (Th1) cells because of the potential high-level production of IL-12 (9) . In addition, CD8α + cDCs are more efficient in the phagocytic uptake of dead cells and in the cross-presentation of cell-bound or soluble antigens on MHC I to generate CTLs than other DC subsets (9) .
CD205, an endocytic type I C-type lectin-like molecule that belongs to the mannose receptor family, is mainly expressed on CD8α
+ cDCs and cortical thymic epithelium, as well as interdigitating DCs in cutaneous lymph nodes (LNs) derived from dermal DCs and epidermal Langerhans cells (LCs), usually at a higher level than seen on macrophages and B cells (10) (11) (12) (13) . CD205 may function as an endocytic receptor involved in the uptake of extracellular antigens. Although an endogenous ligand for CD205 has not been identified, an antigen-conjugated mAb specific for CD205 was internalized, processed in the endosomal compartment, and presented to both MHC II and MHC I for cross-presentation with high efficiency (10) . Although these observations based on analyses in vitro and ex vivo provide the functions of CD205 + cDCs, their role in the immune system under physiological conditions remains unclear because of the lack of a system that selectively eliminates this cell subset in vivo.
To precisely evaluate the contribution of CD205 + cDCs to the immune system, we engineered knock-in mice that express the diphtheria toxin (DT) receptor (DTR) (12, 14, 15) under the control of the Cd205 gene, which allows the selective conditional ablation of CD205 + cDCs in vivo. Using these mice, we demonstrated the unique role of CD205 + cDCs in the control of T-cell responses and homeostasis in vivo.
Results
Inducible Ablation of CD205
+ cDCs in Mice. To allow the specific elimination of CD205 + cDCs in lymphoid tissues in vivo, we created Cd205 dtr/dtr mice harboring cDNA encoding the human DTR fused to enhanced GFP (EGFP) and an internal ribosome entry site (12, 15) into the 3′ UTR of the Cd205 gene (Fig. S1) dtr/dtr →WT chimeras, whereas this treatment had no effect on their frequency and absolute number in WT→WT chimeras ( Fig. 1 A and B and Fig. S2 ). The DT-mediated ablation of CD205 + cDCs occurred in a dose-dependent manner (Fig. 1C) , and near-complete elimination persisted for 2 d, after which their proportions were gradually restored by 7 d (Fig. 1D) . On the other hand, Cd205 dtr/dtr →WT chimeras exhibited increased proportions of CD11c + CD8α − cDCs and CD11c + BST2 + pDCs in spleen (Spl) (Figs. S3A and S4 ), but not in mesenteric LNs (MLNs) (Fig. S5) , until 4 d after the injection with DT, but their cell numbers were returned to the basal levels by day 7 (Fig. S3B) .
We also addressed whether other leukocyte populations are affected by the DT treatment in Cd205 S4) and MLNs (Fig. S5 ) or in the content of thymocytes (Fig. S6 ) in DT-treated Cd205 dtr/dtr →WT chimeras. In addition, analysis of T-cell receptor (TCR) Vβ use revealed that there were no major differences in the formation of the TCR repertoire of thymic and peripheral CD4 + T cells and CD8 + T cells between WT→WT chimeras and DT-treated Cd205 dtr/dtr →WT chimeras (Fig. S7) . However, DT-induced ablation of CD205
+ cDCs led to a slight reduction in the frequency of splenic B220 + B cells (Fig. S4) , although not MLN B220 + B cells (Fig. S5) . We also observed that DT had no effect on the viability of splenic B220 + B cells in vitro, indicating that this reduction might not be because of the direct cytotoxicity of DT.
Taken together, Cd205 →WT chimeras showed a more vigorous proliferation on restimulation with OVA protein than did CD4 + T cells from WT→WT chimeras (Fig. 2B) . Furthermore, CD4
+ T cells from DT-treated Cd205 dtr/dtr →WT chimeras markedly enhanced the production of IFN-γ as well as the frequency of IFN-γ-producing cells (Th1 cells) compared with the cells from WT→WT chimeras (Fig. 2 C and D, and Fig. S8 A and B) .
We also investigated the role of CD205 + cDCs in the antigenspecific differentiation of CD4 
Foxp3
EGFP+ iTregs in Spl 8 d after systemic immunization with OVA protein (Fig. 2E ). An injection with OVA protein efficiently generated OT-II CD4 adoptively transferred with CFSE-labeled OVA-specific OT-I CD8 + T cells (15) were immunized with soluble OVA protein, and their antigen-specific division was measured in Spl 3 d after immunization (Fig. 3A) . DT-treated Cd205 dtr/dtr →WT chimeras showed a marked reduction of antigen-specific division of OT-I CD8 + T cells under steady-state conditions compared with WT→WT chimeras.
To directly prove the influence of the lack of CD205 + cDCs on the generation of CTLs through the cross-presentation of soluble antigen in vivo, chimeric mice were immunized with OVA protein combined with poly (I:C) (a TLR3 ligand) and agonistic anti-CD40 mAb, and we quantified the generation of antigenspecific CD8 + T cells in Spl based on binding with the MHC I-OVA tetramer and OVA-specific intracellular expression of IFN-γ at 6 d later. Immunization of WT→WT chimeras resulted in a marked elevation in serum concentrations of IFN-β and IL12p40 3 h after the immunization (Fig. 3 B and C and Fig. S8C) , and the prominent generation of MHC I-OVA tetramer
high CD8 + T cells and CD8 (Fig. 3 D and E) . However, DT-treated Cd205 dtr/dtr →WT chimeras showed decreased production of serum IL-12p40 (Fig. 3C ) and the impaired generation of OVA-specific CTLs (Fig. 3 D and E) .
Ablation of CD205
+ cDCs Controls T-Cell Homeostasis in Vivo. To determine the impact of the ablation of CD205 + cDCs on T-cell homeostasis, we measured the frequency and number of CD4
+
Foxp3
+ nTregs and CD4 + Teff cells in chimeric mice (Fig. S9) (Fig. 4A) , and was associated with the marked production of serum proinflammatory cytokines 24 h after infection (Fig. 4B and Fig. S8C ). In contrast, DT-treated Cd205 dtr/dtr →WT chimeras showed resistance for 5 d after infection (P < 0.01) (Fig. 4A) , and significantly less production of proinflammatory cytokines and splenic bacterial burden than WT→WT chimeras (Fig. 4 B and C) . However, their survival rates gradually declined 8 d after infection (Fig. 4A) . On the other hand, DT-treated Cd205 dtr/dtr →WT chimeras were more susceptible to bacterial infection than WT→WT chimeras 7 d after infection with a low dose of LM-OVA (5 × 10 5 CFU/mouse) (P < 0.01) (Fig. 4D) .
To clarify the role of CD205 + cDCs in the antibacterial priming of CD4 + T cells or CD8 + T cells in vivo, antigen-specific division of CFSE-labeled OT-II CD4 + T cells or OT-I CD8 + T cells transferred into chimeric mice was measured in Spl 3 d after infection with a low dose of LM-OVA (5 × 10 5 CFU/mouse). DT-treated Cd205 dtr/dtr →WT chimeras exhibited the enhanced antigen-specific division of OT-II CD4 + T cells following infection with LM-OVA (Fig. 4E) , but they showed a decreased antigenspecific response of OT-I CD8 + T cells compared with WT→WT chimeras (Fig. 4F) .
We also examined the influence of the ablation of CD205 + cDCs on the generation of antibacterial CTLs. DT-treated Cd205 dtr/dtr →WT chimeras had a reduced capacity to generate MHC I-OVA tetramer + CD44 high CD8 + T cells in Spl compared with WT→WT chimeras 6 d after infection with a low dose of LM-OVA (5 × 10 5 CFU/mouse) (Fig. 4G ). In addition, DT-treated Cd205 dtr/dtr →WT chimeras showed a higher bacterial burden in Spl 6 d after infection a low dose of LM-OVA (5 × 10 5 CFU/mouse) than WT→WT chimeras (Fig. 4H) . →WT chimeras showed a significant reduction in the production of IL-12p40, but not IFN-β (Fig. S10 A  and B) , but they had a marked reduction of anti-HSV-1 CTLs following infection (Fig. S10 C and D) . In addition, a viral burden in Spl was detected in DT-treated Cd205 dtr/dtr →WT chimeras, but not in WT→WT chimeras, 5 d after infection (Fig. S10E) .
Discussion
In this article, we are unique in reporting the use of a DTRbased knock-in system to generate mice that conditionally lack CD8α +
CD205
+ cDCs and CD8α − CD205 + cDCs to address the role for these cells in the control of innate and adaptive immunity. It had been shown that mice with mutations to several transcription factor genes, including Id2 and Irf8, lack CD8α + cDCs but have additional immune defects (9, 19) . Furthermore, mice deficient in the transcription factor Batf3 reportedly also constitutively lack CD8α
+ cDCs as well as CD103 + CD11b − cDCs, but not other DC subsets, in lymphoid and peripheral tissues (3, 20) . Therefore, we demonstrated that the almost complete and specific conditional ablation of CD8α + CD205 + cDCs and CD8α
−
CD205
+ cDCs provides for the study of their function in the regulation of immune responses in vivo. Previous studies have shown some controversies regarding the influence of the constitutive versus conditional elimination of CD11c + DCs or LCs on immune responses, implying that their chronic ablation allows for the emergence of compensatory mechanisms, which can confound any primary deficits (6, 7, 21, 22) . Therefore, our system allowing inducible ablation of CD205 + cDCs could take an advantageous means to analyze their spaciotemporal role for the control of immune responses.
The observations in Batf3-deficient mice showed that the constitutive lack of CD8α + cDCs had no effect on CD4 + T-cell responses (3) . We showed that the antigen-specific division of splenic CD4
+ T cells was impaired under the conditional ablation of CD8α 
+ cDCs could provide a specific nitch for the bacterial spreading and replication in the Spl that initiate undesirable lethal inflammatory responses during the early phase of an extensive bacterial infection. Conversely, the conditional ablation of CD8α
+ cDCs caused a decrease in the survival of the infected mice that accompanied the abortive generation of antibacterial CTLs and the enhanced splenic bacterial burden after infection with a low dose of bacteria. Taken together, our findings suggest that splenic CD8α + CD205 + cDCs are involved in the initiation of microbial septic shock after the massive bacterial infection, although they are required for the protection against the bacterial organ failure mediated by the cross-priming of CD8 + T cells for generating antibacterial CTLs to efficiently eliminate pathogenic microbes under the lack of lethal bacterial inflammation.
Published reports suggest that dermal CD11c + CD103 + cDCs are the dominant migratory APCs cross-presenting viral antigens to CD8
+ T cells after an infection in the skin or lungs (3, 20, 26, 27) . Our results show that the conditional ablation of splenic CD8α +
+ cDCs abrogated the generation of antiviral CTLs after systemic viral infection independent of type I IFN production. These findings led us to hypothesize that CD8α + CD205 + cDCs located in T-cell areas of Spl predominantly phagocytose virus-infected cells to cross-present viral antigens for the optimal generation of antiviral CTL-responses to eliminate the virus during a systemic infection.
Collectively, our findings demonstrate that CD205 + cDCs play a critical role in controlling T-cell immunity and homeostasis as well as inflammation in vivo. A series of studies have suggested that human blood BDCA3
+ DCs are homologous to mouse CD8α + CD205 + cDCs in terms of their specific gene signature and functionally equivalent for cross-presentation (28). Therefore, further elucidation of CD205 + cDCs might provide insights into immune regulation and pathology, and aid therapeutic interventions for infectious diseases as well as autoimmune and inflammatory disorders.
Materials and Methods
Mice. The following mice were used in this study: C57BL/6 mice (Charles River Laboratories); B6.OT-I TCR transgenic mice harboring OVA-specific CD8 + T cells (15) (15, 29) . All mice were bred and maintained in specific pathogen-free conditions in the animal facility at RIKEN Research Center for Allergy and Immunology in accordance with institutional guidelines.
Immunization. Details of the immunization are described in SI Materials and Methods.
Bacteria, Virus, and Infection. Details of the bacteria, virus, and infection are described in SI Materials and Methods.
Statistical Analysis. Data are expressed as the mean ± SD. The statistical significance of the values obtained was evaluated by ANOVA and the Kaplan-Meier log-rank test. A P value of <0.01 was considered significant.
